Axogen (AXGN) Enterprise Value Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Axogen | 2.00 Bn | 1.90 Bn | 46.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.25% |
| Dec 31, 2025 | 16.77% |
| Sep 30, 2025 | 19.63% |
| Mar 31, 2025 | 24.34% |
| Dec 31, 2024 | 19.08% |
| Sep 30, 2024 | 25.39% |
| Jun 30, 2024 | 27.98% |
| Mar 31, 2024 | 31.13% |
| Dec 31, 2023 | 24.03% |
| Sep 30, 2023 | 23.74% |
| Jun 30, 2023 | 23.70% |
| Mar 31, 2023 | -4.38% |
| Dec 31, 2022 | -5.97% |
| Sep 30, 2022 | -19.23% |
| Jun 30, 2022 | -19.44% |
| Mar 31, 2022 | -21.07% |
| Dec 31, 2021 | -22.88% |
| Sep 30, 2021 | -41.79% |
| Jun 30, 2021 | -40.46% |
| Mar 31, 2021 | -34.12% |
| Dec 31, 2020 | -32.03% |
| Sep 30, 2020 | -28.95% |
| Mar 31, 2020 | -35.83% |
| Dec 31, 2019 | -63.68% |
| Sep 30, 2019 | -55.14% |
| Jun 30, 2019 | -50.40% |
| Mar 31, 2019 | -46.61% |
| Dec 31, 2018 | -43.61% |
| Sep 30, 2018 | -41.11% |
| Jun 30, 2018 | -72.71% |
| Mar 31, 2018 | -22.23% |
| Dec 31, 2017 | -21.29% |
| Sep 30, 2017 | -37.74% |
| Jun 30, 2017 | -38.77% |
| Mar 31, 2017 | -35.65% |
| Dec 31, 2016 | -29.66% |
| Sep 30, 2016 | -8.74% |
| Jun 30, 2016 | -35.88% |
| Mar 31, 2016 | -104.43% |
| Dec 31, 2015 | -33.39% |
| Sep 30, 2015 | -170.34% |
| Jun 30, 2015 | -10.15% |